The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
Shorning BY, Dass MS, Smalley MJ, Pearson HB. · 2020
Read The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. by Shorning BY, Dass MS, Smalley MJ, Pearson HB. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7350257.txt.
Introduction
Shorning and co-authors present a review in the International Journal of Molecular Sciences on prostate cancer signaling. It centers on the PI3K-AKT-mTOR pathway, which is switched on in many prostate tumors. The review traces how this pathway talks with three other key pathways. Those are the androgen receptor, MAPK, and WNT pathways.
The authors outline the gene changes that turn the pathway on. They then show how cross-talk can speed tumor growth and help cancer resist drugs. That resistance affects both pathway-targeted drugs and standard hormone-blocking therapy. Better maps of this network could help sort patients for the right treatment. They could also point to new drug approaches. Readers get a guide to why single-pathway drugs often fail in this cancer.
Catalog record
| CREATOR | Shorning BY, Dass MS, Smalley MJ, Pearson HB. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 167 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |